2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation

Chern En Chiang, Tsu Juey Wu, Kwo Chang Ueng, Tze Fan Chao, Kuan Cheng Chang, Chun Chieh Wang, Yenn Jiang Lin, Wei Hsian Yin, Jen Yuan Kuo, Wei Shiang Lin, Chia Ti Tsai, Yen Bin Liu, Kun Tai Lee, Li Jen Lin, Lian Yu Lin, Kang Ling Wang, Yi-Jen Chen, Mien Cheng Chen, Chen Chuan Cheng, Ming Shien WenWen Jone Chen, Jyh Hong Chen, Wen Ter Lai, Chuen Wang Chiou, Jiunn Lee Lin, San Jou Yeh, Shih Ann Chen

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Atrial fibrillation (AF) is the most common sustained arrhythmia. Both the incidence and prevalence of AF are increasing, and the burden of AF is becoming huge. Many innovative advances have emerged in the past decade for the diagnosis and management of AF, including a new scoring system for the prediction of stroke and bleeding events, the introduction of non-vitamin K antagonist oral anticoagulants and their special benefits in Asians, new rhythm- and rate-control concepts, optimal endpoints of rate control, upstream therapy, life-style modification to prevent AF recurrence, and new ablation techniques. The Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology aimed to update the information and have appointed a jointed writing committee for new AF guidelines. The writing committee members comprehensively reviewed and summarized the literature, and completed the 2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the Management of Atrial Fibrillation. This guideline presents the details of the updated recommendations, along with their background and rationale, focusing on data unique for Asians. The guidelines are not mandatory, and members of the writing committee fully realize that treatment of AF should be individualized. The physician's decision remains most important in AF management.

Original languageEnglish
Pages (from-to)893-952
Number of pages60
JournalJournal of the Formosan Medical Association
Volume115
Issue number11
DOIs
Publication statusPublished - Nov 1 2016

Fingerprint

Cardiology
Taiwan
Atrial Fibrillation
Guidelines
Committee Membership
Ablation Techniques
Anticoagulants
Life Style
Cardiac Arrhythmias
Stroke
Hemorrhage
Physicians
Recurrence
Incidence
Therapeutics

Keywords

  • ablation
  • antiarrhythmic agents
  • anticoagulation
  • atrial fibrillation
  • non-vitamin K antagonist oral anticoagulant
  • vitamin K antagonist

ASJC Scopus subject areas

  • Medicine(all)

Cite this

2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation. / Chiang, Chern En; Wu, Tsu Juey; Ueng, Kwo Chang; Chao, Tze Fan; Chang, Kuan Cheng; Wang, Chun Chieh; Lin, Yenn Jiang; Yin, Wei Hsian; Kuo, Jen Yuan; Lin, Wei Shiang; Tsai, Chia Ti; Liu, Yen Bin; Lee, Kun Tai; Lin, Li Jen; Lin, Lian Yu; Wang, Kang Ling; Chen, Yi-Jen; Chen, Mien Cheng; Cheng, Chen Chuan; Wen, Ming Shien; Chen, Wen Jone; Chen, Jyh Hong; Lai, Wen Ter; Chiou, Chuen Wang; Lin, Jiunn Lee; Yeh, San Jou; Chen, Shih Ann.

In: Journal of the Formosan Medical Association, Vol. 115, No. 11, 01.11.2016, p. 893-952.

Research output: Contribution to journalArticle

Chiang, CE, Wu, TJ, Ueng, KC, Chao, TF, Chang, KC, Wang, CC, Lin, YJ, Yin, WH, Kuo, JY, Lin, WS, Tsai, CT, Liu, YB, Lee, KT, Lin, LJ, Lin, LY, Wang, KL, Chen, Y-J, Chen, MC, Cheng, CC, Wen, MS, Chen, WJ, Chen, JH, Lai, WT, Chiou, CW, Lin, JL, Yeh, SJ & Chen, SA 2016, '2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation', Journal of the Formosan Medical Association, vol. 115, no. 11, pp. 893-952. https://doi.org/10.1016/j.jfma.2016.10.005
Chiang, Chern En ; Wu, Tsu Juey ; Ueng, Kwo Chang ; Chao, Tze Fan ; Chang, Kuan Cheng ; Wang, Chun Chieh ; Lin, Yenn Jiang ; Yin, Wei Hsian ; Kuo, Jen Yuan ; Lin, Wei Shiang ; Tsai, Chia Ti ; Liu, Yen Bin ; Lee, Kun Tai ; Lin, Li Jen ; Lin, Lian Yu ; Wang, Kang Ling ; Chen, Yi-Jen ; Chen, Mien Cheng ; Cheng, Chen Chuan ; Wen, Ming Shien ; Chen, Wen Jone ; Chen, Jyh Hong ; Lai, Wen Ter ; Chiou, Chuen Wang ; Lin, Jiunn Lee ; Yeh, San Jou ; Chen, Shih Ann. / 2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation. In: Journal of the Formosan Medical Association. 2016 ; Vol. 115, No. 11. pp. 893-952.
@article{ed4e50ff3bc6488d9d1f52d407bb0daf,
title = "2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation",
abstract = "Atrial fibrillation (AF) is the most common sustained arrhythmia. Both the incidence and prevalence of AF are increasing, and the burden of AF is becoming huge. Many innovative advances have emerged in the past decade for the diagnosis and management of AF, including a new scoring system for the prediction of stroke and bleeding events, the introduction of non-vitamin K antagonist oral anticoagulants and their special benefits in Asians, new rhythm- and rate-control concepts, optimal endpoints of rate control, upstream therapy, life-style modification to prevent AF recurrence, and new ablation techniques. The Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology aimed to update the information and have appointed a jointed writing committee for new AF guidelines. The writing committee members comprehensively reviewed and summarized the literature, and completed the 2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the Management of Atrial Fibrillation. This guideline presents the details of the updated recommendations, along with their background and rationale, focusing on data unique for Asians. The guidelines are not mandatory, and members of the writing committee fully realize that treatment of AF should be individualized. The physician's decision remains most important in AF management.",
keywords = "ablation, antiarrhythmic agents, anticoagulation, atrial fibrillation, non-vitamin K antagonist oral anticoagulant, vitamin K antagonist, ablation, antiarrhythmic agents, anticoagulation, atrial fibrillation, non-vitamin K antagonist oral anticoagulant, vitamin K antagonist",
author = "Chiang, {Chern En} and Wu, {Tsu Juey} and Ueng, {Kwo Chang} and Chao, {Tze Fan} and Chang, {Kuan Cheng} and Wang, {Chun Chieh} and Lin, {Yenn Jiang} and Yin, {Wei Hsian} and Kuo, {Jen Yuan} and Lin, {Wei Shiang} and Tsai, {Chia Ti} and Liu, {Yen Bin} and Lee, {Kun Tai} and Lin, {Li Jen} and Lin, {Lian Yu} and Wang, {Kang Ling} and Yi-Jen Chen and Chen, {Mien Cheng} and Cheng, {Chen Chuan} and Wen, {Ming Shien} and Chen, {Wen Jone} and Chen, {Jyh Hong} and Lai, {Wen Ter} and Chiou, {Chuen Wang} and Lin, {Jiunn Lee} and Yeh, {San Jou} and Chen, {Shih Ann}",
year = "2016",
month = "11",
day = "1",
doi = "10.1016/j.jfma.2016.10.005",
language = "English",
volume = "115",
pages = "893--952",
journal = "Journal of the Formosan Medical Association",
issn = "0929-6646",
publisher = "Elsevier Science Publishers B.V.",
number = "11",

}

TY - JOUR

T1 - 2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation

AU - Chiang, Chern En

AU - Wu, Tsu Juey

AU - Ueng, Kwo Chang

AU - Chao, Tze Fan

AU - Chang, Kuan Cheng

AU - Wang, Chun Chieh

AU - Lin, Yenn Jiang

AU - Yin, Wei Hsian

AU - Kuo, Jen Yuan

AU - Lin, Wei Shiang

AU - Tsai, Chia Ti

AU - Liu, Yen Bin

AU - Lee, Kun Tai

AU - Lin, Li Jen

AU - Lin, Lian Yu

AU - Wang, Kang Ling

AU - Chen, Yi-Jen

AU - Chen, Mien Cheng

AU - Cheng, Chen Chuan

AU - Wen, Ming Shien

AU - Chen, Wen Jone

AU - Chen, Jyh Hong

AU - Lai, Wen Ter

AU - Chiou, Chuen Wang

AU - Lin, Jiunn Lee

AU - Yeh, San Jou

AU - Chen, Shih Ann

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Atrial fibrillation (AF) is the most common sustained arrhythmia. Both the incidence and prevalence of AF are increasing, and the burden of AF is becoming huge. Many innovative advances have emerged in the past decade for the diagnosis and management of AF, including a new scoring system for the prediction of stroke and bleeding events, the introduction of non-vitamin K antagonist oral anticoagulants and their special benefits in Asians, new rhythm- and rate-control concepts, optimal endpoints of rate control, upstream therapy, life-style modification to prevent AF recurrence, and new ablation techniques. The Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology aimed to update the information and have appointed a jointed writing committee for new AF guidelines. The writing committee members comprehensively reviewed and summarized the literature, and completed the 2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the Management of Atrial Fibrillation. This guideline presents the details of the updated recommendations, along with their background and rationale, focusing on data unique for Asians. The guidelines are not mandatory, and members of the writing committee fully realize that treatment of AF should be individualized. The physician's decision remains most important in AF management.

AB - Atrial fibrillation (AF) is the most common sustained arrhythmia. Both the incidence and prevalence of AF are increasing, and the burden of AF is becoming huge. Many innovative advances have emerged in the past decade for the diagnosis and management of AF, including a new scoring system for the prediction of stroke and bleeding events, the introduction of non-vitamin K antagonist oral anticoagulants and their special benefits in Asians, new rhythm- and rate-control concepts, optimal endpoints of rate control, upstream therapy, life-style modification to prevent AF recurrence, and new ablation techniques. The Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology aimed to update the information and have appointed a jointed writing committee for new AF guidelines. The writing committee members comprehensively reviewed and summarized the literature, and completed the 2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the Management of Atrial Fibrillation. This guideline presents the details of the updated recommendations, along with their background and rationale, focusing on data unique for Asians. The guidelines are not mandatory, and members of the writing committee fully realize that treatment of AF should be individualized. The physician's decision remains most important in AF management.

KW - ablation

KW - antiarrhythmic agents

KW - anticoagulation

KW - atrial fibrillation

KW - non-vitamin K antagonist oral anticoagulant

KW - vitamin K antagonist

KW - ablation

KW - antiarrhythmic agents

KW - anticoagulation

KW - atrial fibrillation

KW - non-vitamin K antagonist oral anticoagulant

KW - vitamin K antagonist

UR - http://www.scopus.com/inward/record.url?scp=85000363073&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85000363073&partnerID=8YFLogxK

U2 - 10.1016/j.jfma.2016.10.005

DO - 10.1016/j.jfma.2016.10.005

M3 - Article

C2 - 27890386

AN - SCOPUS:85000363073

VL - 115

SP - 893

EP - 952

JO - Journal of the Formosan Medical Association

JF - Journal of the Formosan Medical Association

SN - 0929-6646

IS - 11

ER -